Citius Pharmaceuticals, Inc. (CTXR) Financials

CTXR Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 142.3 million 66.3 million
March 31, 2026 132.5 million 63.5 million
Dec. 31, 2025 140.4 million 46.9 million
Sept. 30, 2025 130.9 million 53.4 million

CTXR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 ? ?
March 31, 2026 -1.3 million 3.8 million
Dec. 31, 2025 -13.0 million 4.3 million
Sept. 30, 2025 -11.9 million 2.9 million

CTXR Net Income

No data available :(

CTXR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 17.0 million 7.0 million -
March 31, 2026 4.6 million - 808162
Dec. 31, 2025 7.7 million - 829646
Sept. 30, 2025 4.3 million - 813273

CTXR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 26.2 million
March 31, 2026 22.4 million
Dec. 31, 2025 21.5 million
Sept. 30, 2025 18.1 million

CTXR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 1.1 million 6.1 million -
March 31, 2026 - 1.6 million 26.4 million -
Dec. 31, 2025 - 1.6 million 5.7 million -
Sept. 30, 2025 4 1.6 million 1.2 million -

CTXR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.5 million 491843
March 31, 2026 1.7 million 2.0 million
Dec. 31, 2025 3.9 million 1.4 million
Sept. 30, 2025 - 62038

CTXR

Price: $0.57

52 week price:
0.47
2.19

Earnings Per Share: -2.14 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 674400

Ebitda: -9.5 million

Market Capitalization: 20.7 million

Links: